Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma

Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma

Glioma is a relatively low aggressive brain tumor. Although the median survival time of patients for lower-grade glioma (LGG) was longer than that of patients for glioblastoma, the overall survival was still short. Therefore, it is urgent to find out more effective molecular prognostic markers. The...

Full description

Bibliographic Details
Main Authors:	Jing Feng, Jinping Zhou, Lin Zhao, Xinpeng Wang, Danyu Ma, Baoqing Xu, Feilai Xie, Xingfeng Qi, Gang Chen, Hu Zhao, Junxin Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Genetics
Subjects:	FAM20C lower-grade gliomas LGG biomarker prognosis bioinformatics
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.757014/full

Similar Items

Editorial: Surgical approaches for the treatment of glioma
by: G. La Rocca, et al.
Published: (2022-11-01)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
by: Xinrui Li, et al.
Published: (2022-07-01)

Identification of potential biomarkers related to glioma survival by gene expression profile analysis
by: Justin Bo-Kai Hsu, et al.
Published: (2019-03-01)

Dabrafenib plus Trametinib: A breakthrough in pediatric low‐grade glioma therapy
by: Marrium Sultan Dar, et al.
Published: (2024-01-01)

FAM84B promotes the proliferation of glioma cells through the cell cycle pathways
by: Deshuai Ren, et al.
Published: (2022-11-01)

Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?
by: Monica Capogiri, et al.
Published: (2023-01-01)

Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis
by: Ruofei Liang, et al.
Published: (2023-09-01)

Weighted correlation network analysis identifies multiple susceptibility loci for low‐grade glioma
by: Xiaodong Niu, et al.
Published: (2023-03-01)

The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma
by: Yunhe Han, et al.
Published: (2021-12-01)

Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients
by: Zi-zhuo Li, et al.
Published: (2021-06-01)

Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway
by: Xia Li, et al.
Published: (2022-08-01)

Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma
by: Hanzhang Liu, et al.
Published: (2022-12-01)

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
by: Zewei Tu, et al.
Published: (2022-09-01)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
by: Binfeng Liu, et al.
Published: (2021-09-01)

LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration
by: Cornelis M. van Tilburg, et al.
Published: (2024-01-01)

Transition From Diencephalic Syndrome to Hypothalamic Obesity in Children With Suprasellar Low Grade Glioma: A Case Series
by: Ichelle M. A. A. van Roessel, et al.
Published: (2022-04-01)

Pediatric low-grade glioma models: advances and ongoing challenges
by: Griselda Metta Yvone, et al.
Published: (2024-01-01)

Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma
by: Xiqi Hu, et al.
Published: (2024-01-01)

Noninvasive Prediction of Language Lateralization Through Arcuate Fasciculus Tractography in Patients With Low-Grade Gliomas: Correlation With The Wada Test
by: Dongdong Wu, et al.
Published: (2022-07-01)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
by: Chubei Teng, et al.
Published: (2022-05-01)

DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping
by: Sana Munquad, et al.
Published: (2023-11-01)

Antisense lncRNA CHROMR is linked to glioma patient survival
by: Dovydas Širvinskas, et al.
Published: (2023-03-01)

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
by: Junzhe Liu, et al.
Published: (2022-07-01)

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
by: Lyu L, et al.
Published: (2020-12-01)

CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
by: Fang Wang, et al.
Published: (2022-07-01)

Brain Functional Connectivity in Low- and High-Grade Gliomas: Differences in Network Dynamics Associated with Tumor Grade and Location
by: Luca Pasquini, et al.
Published: (2022-07-01)

Brain Regeneration Resembles Brain Cancer at Its Early Wound Healing Stage and Diverges From Cancer Later at Its Proliferation and Differentiation Stages
by: Yeliz Demirci, et al.
Published: (2022-02-01)

Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications
by: Rongsheng Xu, et al.
Published: (2021-12-01)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
by: Wenyi Wang, et al.
Published: (2021-05-01)

Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma
by: Xing Rong Guo, et al.
Published: (2019-09-01)

FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes
by: Icela Palma-Lara, et al.
Published: (2021-07-01)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
by: Sarah Richtmann, et al.
Published: (2019-05-01)

FAM20B-catalyzed glycosaminoglycans control murine tooth number by restricting FGFR2b signaling
by: Jingyi Wu, et al.
Published: (2020-07-01)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
by: Wen Yin, et al.
Published: (2020-08-01)

Ablation of Fam20c causes amelogenesis imperfecta via inhibiting Smad dependent BMP signaling pathway
by: Jing Liu, et al.
Published: (2020-10-01)

Deep Learning-Based Radiomics for Prognostic Stratification of Low-Grade Gliomas Using a Multiple-Gene Signature
by: Mert Karabacak, et al.
Published: (2023-03-01)

FAM20A Gene Mutation: Amelogenesis or Ectopic Mineralization?
by: Guilhem Lignon, et al.
Published: (2017-05-01)

Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment
by: Shangkun Yuan, et al.
Published: (2022-07-01)

Unravelling the Intricate Roles of FAM111A and FAM111B: From Protease-Mediated Cellular Processes to Disease Implications
by: Danielle Naicker, et al.
Published: (2024-02-01)

Quantification of FAM20A in human milk and identification of calcium metabolism proteins
by: Vaksha Patel, et al.
Published: (2021-12-01)